Sarepta establishes 2026 Equity Incentive Plan with 6.74M share pool

Sarepta Therapeutics adopted a new equity incentive plan authorizing 6.74 million shares for stock and stock-based awards to employees and participants. The plan replaces prior equity plans and includes standard provisions for stock options, SARs, and other equity awards with administrative discretion vested in the plan administrator.